← SynDRA
SACUBITRIL
SynDRA canonical compound SYN0037834 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | MME |
|---|
| Mechanism of action | Neprilysin inhibitor |
|---|
| Indication | congestive heart failure |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Neprilysin inhibitor
- MME INHIBITOR
ATC classes
- ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
Cross-references
Synonyms
- AHU377
- sucabitril
- Sacubitrilo
- AHU-377
- Sacubitril component of entresto
- AHU 377
- ENTRESTO COMPONENT SACUBITRIL
- sacubitrilum
- RefChem:884341
- DTXCID3086861
- MFCD00920862
- Sacubitril [USAN:INN]
- UNII-17ERJ0MKGI
- Neparvis
- SACUBITRIL [MI]
- SACUBITRIL [INN]
- SACUBITRIL [JAN]
- SACUBITRIL [USAN]
- LCZ-696 Impurity 3
- SACUBITRIL [WHO-DD]
- Sacubitril (JAN/USAN/INN)
- GTPL7857
- orb1302745
- Sacubitril - Bio-X trade mark
- SCHEMBL2707112
- SACUBITRIL [ORANGE BOOK]
- CHEBI:134714
- PYNXFZCZUAOOQC-UTKZUKDTSA-N
- GLXC-04735
- EBC-26994
- MSK160284
- AKOS027321509
- FB71505
- NCGC00387800-02
- NCGC00387800-07
- AC-28899
- AS-16703
- FS183789
Reported adverse events
- Angioedema
- Cough
- Dizziness
- Hypersensitivity
- Hypotension
- Renal failure
- Fall
- Adverse reaction
Look up SACUBITRIL in the interactive SynDRA portal →